Patisiran in Patients with Transthyretin Cardiac Amyloidosis. Reply
N Engl J Med
.
2024 Jan 18;390(3):286-287.
doi: 10.1056/NEJMc2313408.
Authors
Mathew S Maurer
1
,
Julian D Gillmore
2
Affiliations
1
Columbia University Irving Medical Center, New York, NY msm10@cumc.columbia.edu.
2
University College London, London, United Kingdom.
PMID:
38231633
DOI:
10.1056/NEJMc2313408
No abstract available
Publication types
Letter
Comment
MeSH terms
Amyloid Neuropathies, Familial* / complications
Amyloid Neuropathies, Familial* / therapy
Humans
Prealbumin* / genetics
RNA, Small Interfering / adverse effects
Substances
patisiran
Prealbumin
RNA, Small Interfering